Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 11 - 20 of about 157   

Articles published

AZN 5,060.03 +33.03 (0.66%)
price chart
AstraZeneca Plc (NYSE:AZN) Gets European Commission Approval For Qtern
The US Food and Drug Administration (FDA) may have favored the generic version of Crestor, the cholesterol-lowering drug of AstraZeneca plc (NYSE:AZN), but the company has won the approval of the European Commission for Type 2 diabetes drug, Qtern.
AstraZeneca plc Lost the Battle, What's Next!  Business Finance News
AstraZeneca Fails to Keep Generic Crestor Rivals Off Market  Bloomberg
Price Target Highlight: AstraZeneca PLC (NYSE:AZN)
The Company gained 1.97% and finished at $31.13. The daily volume was measured at 12.32 million shares. The 52-week high of the share price is $34.88 and the 52-week low is $26.97.
Astrazeneca PLC (AZN) Shares are Up 2.94%  Trade Calls
Astrazeneca PLC (AZN) Rating Increased to Buy at TheStreet  Community Financial News
Successful lung cancer drug trial boosts AstraZeneca
AstraZeneca's executive vice-president of global medicine development and chief medical officer, Sean Bohen, said: "These results confirm Tagrisso as a meaningful alternative to benefit EGFR T790M lung cancer patients.
AstraZeneca plc to Boost Advanced Lung Cancer Program  Business Finance News
ASTRAZENECA PLC ANNOUNCES TAGRISSO MET PRIMARY ENDPOINT IN PHASE III 2ND ...  PharmiWeb.com (press release)
AstraZeneca plc 5.2% Potential Upside Indicated by JP Morgan Cazenove
AstraZeneca plc using EPIC/TICKER code LON:AZN has had its stock rating noted as 'Reiterates' with the recommendation being set at 'NEUTRAL' today by analysts at JP Morgan Cazenove.
Astrazeneca PLC (AZN) Receives "Hold" Rating from Shore Capital  The Cerbat Gem
Analysts Rating Overview: Astrazeneca PLC (NYSE:AZN) , Juno Therapeutics ...  Street Updates
Why AstraZeneca PLC Stock Rose in June
What: Shares of AstraZeneca PLC (NYSE:AZN), a British-based big pharma, bucked the trend, rising 2.5% last month, according to data from S&P Global Market Intelligence.
Analysts Issue Forecasts for Astrazeneca PLC's FY2020 Earnings (AZN)  The Cerbat Gem
Astra Faces Off With FDA on Copies of $7 Million-a-Day Drug  Bloomberg
Most recent Analysts Rating report: Astrazeneca PLC (NYSE:AZN) , Pacific ...
On 7/25/2016, shares of Astrazeneca PLC (NYSE:AZN) rose +0.06% in trading session and finally closed at $31.15. The company most recent volume stood at 8.19 million shares as compared to average volume of 5.14 million shares.
Earnings Preview: AstraZeneca PLC (NYSE:AZN) moved down 6 times out of last 9 ...
AstraZeneca PLC (NYSE:AZN) is expected to announce second quarter financial results before market open (confirmed) on July 28, 2016.
One-Year Projected Target Prices by Analysts: Astrazeneca PLC (NYSE:AZN ...  Is stories
AstraZeneca (AZN) Upcoming Earnings: What matter for investors?  The Voice Registrar
Take a look at Analysts Tips: Astrazeneca PLC (NYSE:AZN) , Express Scripts ...
On 7/27/2016, shares of Astrazeneca PLC (NYSE:AZN) rose +2.04% in trading session and finally closed at $31.54. The company most recent volume stood at 9.42 million shares as compared to average volume of 5.29 million shares.
Reliable stocks in today's share market: AstraZeneca PLC (NYSE:AZN)
The market cap of 86685.12 for AstraZeneca PLC in today's market indicated its current strength, making the company's shares a lucrative one.
AstraZeneca plc 18.2% Potential Upside Indicated by Berenberg
AstraZeneca plc using EPIC/TICKER code LON:AZN has had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' today by analysts at Berenberg.
AstraZeneca plc (AZN) Stock Rating Reaffirmed by Shore Capital  BBNS
AstraZeneca plc's (AZN) Underperform Rating Reiterated at Credit Suisse ...  Community Financial News